Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

From carotid plaque biology to serologic markers of vulnerability to predict the risk of cerebrovascular events.

Cola C, Clementi E, Biondi-Zoccai G, Sangiorgi G.

Acta Chir Belg. 2007 Mar-Apr;107(2):129-42. Review.

PMID:
17515260
2.

[Unstable carotid plaque: biochemical and cellular marker of vulnerability].

Carbone GL, Mauriello A, Christiansen M, Oxvig C, Spagnoli LG, Schwartz RS, Sangiorgi G.

Ital Heart J Suppl. 2003 May;4(5):398-406. Review. Italian.

PMID:
12848077
3.

[Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].

Sertić J, Skorić B, Lovrić J, Bozina T, Reiner Z.

Acta Med Croatica. 2010 Oct;64(4):237-45. Review. Croatian.

PMID:
21688606
4.

Lp-PLA2: a new kid on the block.

Zalewski A, Nelson JJ, Hegg L, Macphee C.

Clin Chem. 2006 Sep;52(9):1645-50. Epub 2006 Jul 27. Review.

5.

Identifying the vulnerable patient with rupture-prone plaque.

Weintraub HS.

Am J Cardiol. 2008 Jun 16;101(12A):3F-10F. doi: 10.1016/j.amjcard.2008.04.013.

PMID:
18549869
6.

Candidate biomarkers for the detection of coronary plaque destabilization and rupture.

Prasad A, Tsimikas S.

Curr Atheroscler Rep. 2008 Aug;10(4):309-17. Review.

PMID:
18618976
7.

Pregnancy-associated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events.

Sangiorgi G, Mauriello A, Bonanno E, Oxvig C, Conover CA, Christiansen M, Trimarchi S, Rampoldi V, Holmes DR Jr, Schwartz RS, Spagnoli LG.

J Am Coll Cardiol. 2006 Jun 6;47(11):2201-11. Epub 2006 May 15.

8.

Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.

Anderson JL.

Am J Cardiol. 2008 Jun 16;101(12A):23F-33F. doi: 10.1016/j.amjcard.2008.04.015. Review.

PMID:
18549868
9.

Biobanks and the search for predictive biomarkers of local and systemic outcome in atherosclerotic disease.

Hurks R, Peeters W, Derksen WJ, Hellings WE, Hoefer IE, Moll FL, de Kleijn DP, Pasterkamp G.

Thromb Haemost. 2009 Jan;101(1):48-54. Review.

PMID:
19132188
10.

Association of high-density lipoprotein levels and carotid atherosclerotic plaque characteristics by magnetic resonance imaging.

Phan BA, Chu B, Polissar N, Hatsukami TS, Yuan C, Zhao XQ.

Int J Cardiovasc Imaging. 2007 Jun;23(3):337-42. Epub 2006 Nov 4.

PMID:
17086362
11.

Role of inflammation in atherosclerosis.

Spagnoli LG, Bonanno E, Sangiorgi G, Mauriello A.

J Nucl Med. 2007 Nov;48(11):1800-15. Epub 2007 Oct 17.

12.

The vulnerable patient: refocusing on the plaque?

Eijgelaar WJ, Heeneman S, Daemen MJ.

Thromb Haemost. 2009 Aug;102(2):231-9. doi: 10.1160/TH09-01-0030. Review.

PMID:
19652873
13.

Coronary artery imaging in the new millennium.

Worthley SG, Farouque HM, Helft G, Meredith IT.

Heart Lung Circ. 2002;11(1):19-25.

PMID:
16352064
14.

Imaging the cellular biology of the carotid plaque.

U-King-Im JM, Tang T, Moustafa RR, Baron JC, Warburton EA, Gillard JH.

Int J Stroke. 2007 May;2(2):85-96. doi: 10.1111/j.1747-4949.2007.00123.x. Review.

PMID:
18705959
15.

[The correlation of human serum Lp-PLA2 and hs-CRP and stability of coronary atherosclerotic plaques].

Xu DL, Liu JN, Du YM, Yao GH, Jiang WD, Wang X, Dong ZQ, Hao L, Wang GY, Sui SJ, Li JF, Lu QH.

Zhonghua Nei Ke Za Zhi. 2009 Aug;48(8):651-4. Chinese.

PMID:
19954057
16.

Intravascular modalities for detection of vulnerable plaque: current status.

MacNeill BD, Lowe HC, Takano M, Fuster V, Jang IK.

Arterioscler Thromb Vasc Biol. 2003 Aug 1;23(8):1333-42. Epub 2003 Jun 12. Review.

17.

Carotid plaque morphologic characteristics.

Aidinian G, Weiswasser JM, Arora S, Abularrage CJ, Singh N, Sidawy AN.

Perspect Vasc Surg Endovasc Ther. 2006 Mar;18(1):63-70. Review.

PMID:
16628337
18.

Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.

Corson MA, Jones PH, Davidson MH.

Am J Cardiol. 2008 Jun 16;101(12A):41F-50F. doi: 10.1016/j.amjcard.2008.04.018. Review.

PMID:
18549871
19.

CRP and the risk of atherosclerotic events.

Calabrò P, Golia E, Yeh ET.

Semin Immunopathol. 2009 Jun;31(1):79-94. doi: 10.1007/s00281-009-0149-4. Epub 2009 May 5. Review.

PMID:
19415283
20.

Lp-PLA(2) as a marker of cardiovascular diseases.

Bhatti S, Hakeem A, Cilingiroglu M.

Curr Atheroscler Rep. 2010 Mar;12(2):140-4. doi: 10.1007/s11883-010-0095-6. Review.

PMID:
20425250

Supplemental Content

Support Center